New Antibiotic Hits the Market to Tackle Stubborn UTIs
The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...
Medscape1 天
Topical Antibiotic Treatment for Uncomplicated Skin and Skin Structure Infections: Review ...
Because the effectiveness of the current oral options ... review discusses various topical antibiotic treatment options for uncomplicated skin infections, including over-the-counter and prescribed ...
Medscape1 天
Update on Antibiotics for Infection Control in Cystic Fibrosis
aeruginosa infection can often receive adequate ... pulmonary exacerbations utilizes combinations of oral, inhaled and intravenous antibiotic agents. Chronic use of aerosolized antibiotics such ...
Dr. Kube: Patient unhappy when told antibiotics not useful for treating his virus loses cool
An ED patient unhappy Dr. Kube would not give him antibiotics for his virus because they aren't useful began yelling and ...
McKnight's Long-Term Care News8 天
FDA approves new antibiotic for uncomplicated UTIs
The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...
FiercePharma12 天
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
Becker's Hospital Review7 天
FDA approves another new antibiotic
FDA approves new oral antibiotic for uncomplicated urinary tract infections in women with limited treatment options. Orylnvah shows superior response rates ...
BioSpace9 天
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...